tiprankstipranks

James T. Parsons Insider Profile

4 Followers
James T. Parsons, Director at Diamedica Therapeutics, holds 59.94K shares in Diamedica Therapeutics (Ticker: DMAC), holds 0.00 shares in Trillium Therapeutics (Ticker: TRIL).
tipranks
James T. Parsons

James T. Parsons
Diamedica Therapeutics (DMAC)
Director

Not Ranked
James T. Parsons has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$180K
100.00%
A breakdown of James T. Parsons's holdings

Insider Roles

Diamedica Therapeutics
(DMAC)
Director
Roles that James T. Parsons holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by James T. Parsons

James T. Parsons's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Diamedica Therapeutics
Jan 02, 2024
Director
Uninformative Buy
60.00K
$179.81K
TRIL
Trillium Therapeutics
Jan 12, 2021
Uninformative Sell
134.21K
$0.00
List of latest transactions for each holding click on a transaction to see James T. Parsons's performance on stock

James T. Parsons insider profile FAQ

What is the percentage of profitable transactions made by James T. Parsons?
The percentage of profitable transactions made by James T. Parsons is ―.
    What is the average return per transaction made by James T. Parsons?
    The average return per transaction made by James T. Parsons is ―.
      What stocks does James T. Parsons hold?
      James T. Parsons holds: DMAC, TRIL stocks.
        What was James T. Parsons’s latest transaction?
        James T. Parsons latest transaction was an Uninformative Buy of $60.00K.
          What was James T. Parsons's most profitable transaction?
          James T. Parsons’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is James T. Parsons's role in Diamedica Therapeutics?
            James T. Parsons's role in Diamedica Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.